Dr Amol Akhade
@SuyogCancer
Oncology care , to give or not to give chemo , data analysis , oncology pharamocovigilance , enthusiastic critic, twitts are not twists
04-06-2019 16:07:29
6,4K Tweets
3,0K Followers
121 Following
Nice article in Journal of Clinical Oncology about current evidence and ongoing trials for optimizing post neoadjuvant treatment in EBC pts who get PCR.
Note that ctDNA based MRD has not yet proven to be beneficial for treatment decisions for EBC. We need better biomakers. Great article by π
